Topic: [ANN][INNBC]INNOVATIVE BIORESEARCH 💚 Funding AIDS cure research*get JDM cars 🚗 - page 9. (Read 17804 times)

Thanks. This is our mission.

You are welcome. Please feel free to ask any other question.

INNBC is a great idea to help people with this deadly disease, with a special research on AIDS and will ease the burden of AIDS sufferers

The INNBC project is the perfect solution for people with AIDS. With this project will greatly assist the medical world in finding a cure from this deadly disease

Great explanation, thanks for clarifying

Thanks for your question. The target of our medical treatment is the HIV seropositive population. However, the target of our "You're not alone" app will not be just the HIV seropositive population, but anyone who is interested in the research itself and want to be part of the community and contribute to make it grow. There will be incentivations to do so. First, members who make particuparly useful posts to help other memebers will be rewarded with INNBC Tokens. Second, and most importantly, INNBC Tokens will be be spendable to access moderation roles in the forum community, and moderators will earn the 1% of the revenue generated by in app ads. So the target market is anyone who is interested in being a member of the community and earn INNBC Tokens, or being a forum moderator and earn from in app ads.

Also, INNBC Tokens will be spendable to buy classic iconic JDM cars. So anyone who is interested about cars can join the community, can earn INNBC Tokens, and then spend them on the INNBC JDM ONLINE GARAGE.

https://i.imgur.com/NGuLguR.jpg

As you can see, the target audience of our project is very broad and not limited to HIV seropositive people.

INNOVATIVE BIORESEARCH is a project that focuses on new healing research on HIV, cancer and regeneration research. What is the specific target market of people affected by HIV or humanitarian institutions?
what kind of community will be built?

This is a type of a very successful project.

Thank you very much for the interest in the project. This is a long term project that involves not just the blockchain implementation but our AIDS cure research as well

Hello. This is the timeline for our project.

https://i.imgur.com/nptCgSr.jpg

●Token pre-sale. 1 May 2018- 15 June 2018
●Token Sale. 16 June 2018 - 1 Aug 2018
●JDM Online Garage. Our online garage will be launched shortly after the Token sale, so we expect it to be ready by the beginning of August 2018.
●AIDS research. We will start contracting our partners to perform preclinical animal research on SupT1 cell infusion therapy immediately upon Token sale completion. We expect to start animal research by October 2018, and to complete it by December 2019. We expect to start human trials by mid 2020 and conclude human experimentation (Phase 1,2,3 trials) in 5-8 years. So we expect to have SupT1 cell infusion therapy commercially available by 2025-2028.
●You’re not alone app. We expect to launch the application within 3-6 months after Token sale ends, so we expect it to launch between November 2018 and February 2019.

Sure.

​INNBC Tokens will be automatically distributed to investors immediately after purchase. However, they will be transferable out of your wallet only upon crowdsale completion. The InnovativeBioresearchCoin (INNBC) is an ERC20 Token released on the Etherum blockchain (official ERC20 Token address: 0x85558055812f19eB084B8bA327470e84Ad795b11). There will be one initial limited supply and only Tokens sold are actually minted upon purchase. Therefore, total supply will be sold Tokens (with a hard cap of 20,000,000INNBC for the pre sale and 30,000,000INNBC for the sale) plus Tokens reserved by Innovative Bioresearch. Tokens reserved by Innovative Bioresearch will be used for Token economy and are not available for sale. Pre sale starts 1 May 2018 and ends 15 June 2018, while main sale starts 16 June 2018 and ends 1 August 2018. INNBC Token emission price is 1EUR (1,23USD) per 1INNBC, corresponding to 0,0024ETH (415INNBC per 1ETH), with respect to the ETH/EUR exchange rate on 16 April 2018, when the pricing was set.


During INNBC Token sale, we will offer the following discounts

●20% discount for pre-sale (1 May 2018- 15 June 2018): 1INNBC= 0,002ETH (498INNBC per 1ETH).
●10% discount for the successive sale (16 June 2018 - 1 Aug 2018): 1INNBC= 0,0022ETH (456INNBC per 1ETH).

Can I have more info on Token distribution?

Many people believe in the future of project and me too

Thanks for the support. Really appreciated.

Thank you very much. We need your support to make this project a success not just for the blockchain industry but for the biotech industry as well.

awesome project, following closely.

ICO listed on

https://www.coinschedule.com/ico/innovativebioresearchcoin

https://www.ico-list.com/Index/detail/id/508.html

https://longcatchain.com/ico/innovative-bioresearch

https://www.icoalert.com/?q=innovative%20bioresearch&is_v=1

https://foundico.com/ico/innovative-bioresearch.html

https://icoslot.com/en/ico/innovative-bioresearch/

https://icoholder.com/en/innovative-bioresearch-ico-21504

Pretty sure I am missing something. Will update the list as we are notified.

INNOVATIVE BIORESEARCH Launches INNBC Token Sale to Develop Novel AIDS Cure Research, Decentralized Clinical Data, and the first Token backed by the value of JDM cars

INNOVATIVE BIORESEARCH, a biotech company specialized in HIV, cancer and regeneration research, launched INNBC Token sale to develop their novel cell-based therapy for HIV, along with an app named “You’re not alone” providing on one hand a decentralized database for clinical data, and on the other hand a social platform to provide information, support and services to the HIV positive community. In addition, the INNBC Token will be spendable to buy classic iconic JDM cars, and as such it will be backed by the value of actual physical goods. INNBC Token sale is something unique among current ICO offerings.

-First ICO launched by a Biotech Company for funding novel AIDS cure research, with the goal of developing SupT1 cell infusion therapy, a low cost, cell-based therapy for HIV to allow access to the treatment where access to traditional costly HIV antiretroviral treatment is hampered by social and/or economic limitations. “Because although we are a for profit company, we do have a coscience”.

-Creation of the first decentralized database for processing clinical data, with an application designed by a research scientist to ease the process of performing research. The blockchain technology provides some specific features that make it an ideal application for scientific data, such as immutability (scientific data need to be immutable), decentralization (scientific data need to be publicly shared), and secutity (smart contracts are almost impossible to compromise).

-The “You’re not alone” app will provide a social platform for the HIV seropositive community, where they can start topics and discussions, and find information and support about the seropositive condition. “We hope to create a community were the HIV seropositive people can stand together and not feel alone in their battle against AIDS”. The INNBC Token will be spendable in the app ecosystem to access moderation roles and earn from in app ads. INNBC Tokens will also be rewarded to members who make particularly useful contributions helping other members in the forum topics.

-The INNBC Token will be spendable to buy wonderful iconic JDM cars such as Skylines, Supras, Subarus and Evos from the INNBC JDM ONLINE GARAGE that will be launched right after the Token sale, which will offer amazing deals and worldwide shipping. Tokens are not usually backed by the value of actual physical goods, which means there is nothing stopping them from falling in value other than trust in the platform. “However, we wanted to provide something more for INNBC Token holders. Here at Innovative Bioresearch we love JDM cars. Because, let’s face it; imports will always beat muscle cars! Therefore, we wanted the INNBC Token to be backed by the value of wonderful JDM cars. We believe that providing such a straightforward utility (i.e., you can directly use the INNBC Token to buy physical goods as you would with a fiat currency) can seriously help reaching those customers who are not normally into the crypto world”.

INNBC Token sale starts 1 May 2018. 20% discount at pre-sale. Get more info at https://www.innovativebioresearch.com/pre-ico

HOW WE OPERATE

For research projects, Jonathan Fior works as PI (principal investigator), conceiving the experiments and writing the experiment protocol. The work is then commissioned to a Contract Research Organization (CRO), which physically performs the experiments. Jonathan Fior then supervises all aspects related to the research communicating closely with the CRO. Once the experiments are completed, he analyzes the results and writes a scientific paper, which is published in a peer reviewed scientific journal. This means that although our team is not a large team, we actually have companies with 100+ people working for us. This way we can keep a small, yet strong and great, team. To maximise results  and reducing costs, we perform our highly specialized research by partnering with state-of-the-art CROs and Institutions. Some CROs we hired in the past are listed below

AXENIS

BERTIN PHARMA

Social media links:

Jonathan Fior, Owner and Chief Scientific Officer. He is the head of the company.  
Facebook
Twitter
Pubmed
Linkedin

Davide Bosetti, Social Media Manager.
Facebook
Linkedin

Alessandro Gatti, Chief Legal Officer
Facebook
Linkedin

Great. Our INNBC Token is now officially verified by etherscan 

https://etherscan.io/token/0x85558055812f19eb084b8ba327470e84ad795b11